Biocon ties up with DKSH for distribution of seven products in Singapore, Thailand

Bio-technology major Biocon has inked a pact with market expansion services provider DKSH for distribution of seven generic products in Singapore and Thailand.
Biocon Pharma Limited is a subsidiary of the bio-tech firm and DKSH Business Unit Healthcare, have inked an agreement in this regard.
Under the terms of the pact, DKSH will gain an exclusive license to register and commercialise the seven generic formulations from various therapeutic areas like diabetology, cardiology, oncology and immunology, which will be sold under Biocon’s brand in Singapore and Thailand.